PLAC8 and neoplasm: Since the expression of RBP4 and PLAC8 were increased in tumor cells in PC3-GFP/PC3-OPG-injected mice compared to controls, RBP4 and PLAC8 may be acting as survival factors in prostate cancer cells when osteolytic tumor growth is inhibited by OPG.